{mosads}OMB praised the Senate bill for creating a new user fee for the review of generic drugs, which President Obama has proposed in his budget requests.

“In addition, provisions in the bill help address the challenges of globalization by enhancing the safety of the drug supply chain, increase incentives for the development of new antibiotics, renew and enhance mechanisms to ensure that children’s medicines are appropriately tested and labeled, and expedite the development and review of certain drugs for treatment of serious or life-threatening diseases and conditions,” OMB said.

The House version of the FDA bill easily cleared the Energy and Commerce Committee and is ready for a floor vote.


The Hill has removed its comment section, as there are many other forums for readers to participate in the conversation. We invite you to join the discussion on Facebook and Twitter.

See all Hill.TV See all Video

Most Popular

Load more


See all Video